New RNA vaccine shows promise in massive COVID-19 trial
NCT ID NCT05012943
First seen Nov 06, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tested a new type of COVID-19 vaccine called ARCT-154, which uses self-amplifying RNA to boost immune responses. Nearly 20,000 adults in Vietnam took part, including those with health conditions that raise COVID-19 risk. The goal was to see if the vaccine is safe, triggers strong antibodies, and prevents COVID-19 illness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 VACCINES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hanoi Medical University
Hanoi, Hanoi, 00000, Vietnam
-
Military Medical University
Hanoi, Hanoi, 00000, Vietnam
-
Pasteur Institute
Ho Chi Minh City, Ho Chi Minh, 00000, Vietnam
Conditions
Explore the condition pages connected to this study.